The developing world in The New England Journal of Medicine

Lown, Bernard; Banerjee, Amitava

doi:10.1186/1744-8603-2-3

Cited by 27 publications

(13 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A previous review, published in the New England Journal of Medicine between 1997 and 2004, reported less than 3% of research-addressed health issues in the developing world, and the majority of this addressed communicable diseases including HIV 23. A further review reported that >90% of published research by scientists comes from just 20 countries 24.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification

et al. 2013

View full text Add to dashboard Cite

IntroductionPrevalence of non-communicable diseases (NCDs) is increasing globally, with the greatest projected increases in low-income and middle-income countries. We sought to quantify the proportion of Cochrane evidence relating to NCDs derived from such countries.MethodsWe searched the Cochrane database of systematic reviews for reviews relating to NCDs highlighted in the WHO NCD action plan (cardiovascular, cancers, diabetes and chronic respiratory diseases). We excluded reviews at the protocol stage and those that were repeated or had been withdrawn. For each review, two independent researchers extracted data relating to the country of the corresponding author and the number of trials and participants from countries, using the World Bank classification of gross national income per capita.Results797 reviews were analysed, with a reported total number of 12 340 trials and 10 937 306 participants. Of the corresponding authors 90% were from high-income countries (41% from the UK). Of the 746 reviews in which at least one trial had met the inclusion criteria, only 55% provided a summary of the country of included trials. Analysis of the 633 reviews in which country of trials could be established revealed that almost 90% of trials and over 80% of participants were from high-income countries. 438 (5%) trials including 1 145 013 (11.7%) participants were undertaken in low-middle income countries. We found that only 13 (0.15%) trials with 982 (0.01%) participants were undertaken in low-income countries. Other than the five Cochrane NCD corresponding authors from South Africa, only one other corresponding author was from Africa (Gambia).DiscussionThe overwhelming body of evidence for NCDs pertains to high-income countries, with only a small number of review authors based in low-income settings. As a consequence, there is an urgent need for research infrastructure and funding for the undertaking of high-quality trials in this area.

show abstract

Section: Discussionmentioning

confidence: 99%

“…But the medical information gap between rich and poor countries appears to be larger than the gap in funding for research 23. Commercial efforts are too often focused on where the money is—in providing end products to health professionals 30.…”

Section: Implication For Practice and Researchmentioning

confidence: 99%

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification

et al. 2013

View full text Add to dashboard Cite

show abstract

“…A study by Lown & Banerjee to assess the New England Journal of Medicine's coverage of health issues of the developing world, found that in 416 weekly issues over an eight-year period < 3% of articles were devoted to such issues. 18 Other studies have shown similar evidence of systematic bias by medical journals from developed countries against highlighting diseases of poverty, and recent reports have documented the problem of neglected tropical diseases. 19,20 Overcoming the limitations The statement and recommendations of the Budapest Open Access Initiative on which all subsequent open access developments are based, is concerned with free public access to peer reviewed publicly-funded research publications.…”

Section: Solutionsmentioning

confidence: 75%

Open access: a giant leap towards bridging health inequities

Chan¹,

Arunachalam²,

Kirsop³

2009

Bull World Health Org

View full text Add to dashboard Cite

Access to health research publications is an essential requirement in securing the chain of communication from the researcher to the front-line health worker. As the diagram of the knowledge cycle from the Canadian Institutes of Health Research shows, health knowledge generated in the world's laboratories is passed down the information chain through publications, through its impact and application, its subsequent "translation" into appropriate contexts for different user communities, arriving finally with health workers and the general public. This article focuses on the first link in the chain, from research author to reader, and the free online access to peer-reviewed published articles that are the building blocks for future health innovation developments.Une traduction en français de ce résumé figure à la fin de l'article. Al final del artículo se facilita una traducción al español. ‫املقالة.‬ ‫لهذه‬ ‫الكامل‬ ‫النص‬ ‫نهاية‬ ‫يف‬ ‫الخالصة‬ ‫لهذه‬ ‫العربية‬ ‫الرتجمة‬

show abstract

“…Poverty reduction strategy papers, as mentioned within Labonte and Torgerson’s framework [2], were evident, with a focus on the conceptualisation of aid [12] and on alignment of spending and domestic priorities [13]. The development of research was a topic within this; authors focused upon under-representation of low-income countries in the literature, research partnerships and ethical standards of research [14–16]. Sustainability of global and local initiatives were also covered [17], as was the concept of ‘reverse innovation’ [18].…”

Section: Resultsmentioning

confidence: 99%

Globalization and Health: developing the journal to advance the field

et al. 2016

View full text Add to dashboard Cite

Founded in 2005, Globalization and Health was the first open access global health journal. The journal has since expanded the field, and its influence, with the number of downloaded papers rising 17-fold, to over 4 million. Its ground-breaking papers, leading authors -including a Nobel Prize winner-and an impact factor of 2.25 place it among the top global health journals in the world. To mark the ten years since the journal's founding, we, members of the current editorial board, undertook a review of the journal's progress over the last decade. Through the application of an inductive thematic analysis, we systematically identified themes of research published in the journal from 2005 to 2014. We identify key areas the journal has promoted and consider these in the context of an existing framework, identify current gaps in global health research and highlight areas we, as a journal, would like to see strengthened.

show abstract

The developing world in The New England Journal of Medicine

Abstract: Background: Rampant disease in poor countries impedes development and contributes to growing North-South disparities; however, leading international medical journals underreport on health research priorities for developing countries.

Cited by 27 publications

References 11 publications

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification

Open access: a giant leap towards bridging health inequities

Globalization and Health: developing the journal to advance the field

Contact Info

Product

Resources

About